WTCHP Releases Updated Coverage Details on Dental Services and MGUS
Monoclonal Gammopathy of Undetermined Significance (MGUS) is a benign condition that many 9/11 toxin exposure victims have been diagnosed with. Periodically, the World Trade Center Health Program (WTCHP) will provide updates regarding what medical services are covered under the program. While MGUS is not a cancer and not considered a 9/11-related condition by the WTCHP or the September 11th Victim Compensation Fund (VCF), it is a condition that suggests cancer may develop later in life. Recently, the WTCHP released updated coverage information concerning dental services and MGUS.
Updated Dental Services
Limited pre-treatment dental services are now available for WTCHP members who suffer from one or more of the following:
- A certified 9/11-related head/neck cancer; and/or
- A member who will be receiving treatment for any certified 9/11-related cancer; and/or
- A member with a planned 9/11-related organ transplant.
Previously, limited dental services were only provided to WTCHP members who had a certified 9/11-related head/neck cancer. The expansion of limited dental services will reach a broader population of 9/11 victims who are in desperate need of such care.
Coverage for MGUS
MGUS is not considered a 9/11-related condition. The WTCHP covers screening of MGUS, however, with certain limitations. Individuals who have not yet been certified as having a 9/11-related condition may receive free MGUS testing as part of the initial health evaluation period. On the other hand, individuals who have already been certified as having a 9/11-related condition may receive MGUS services whenever deemed medically necessary by a WTCHP healthcare provider.
Follow-up screening and evaluations are covered when a WTCHP member with a certified 9/11-related condition has either been diagnosed with MGUS or has symptoms of a plasma cell neoplasm, which are abnormal changes to plasma cells. Because routine screening of MGUS is not medically necessary, the WTCHP will not automatically cover such screening, absent authorization by a WTCHP Clinical Center of Excellence or the Nationwide Provider Network Clinical Director.
Overall, 9/11 survivors and responders who qualify to receive medical monitoring but who have not as yet been diagnosed with a certified 9/11-related condition may only receive MGUS screening in the initial standard cancer diagnostic screening process. Even if a screening-eligible WTCHP member is diagnosed with MGUS, additional screening and evaluation will only become available and covered should the member be diagnosed with a certified 9/11-related condition such as cancer.
Contact the 9/11 Lawyers of Pitta & Baione LLP Today
If you are a 9/11 responder or survivor and believe you are eligible to become a WTCHP member, it is important to speak with a 9/11 benefits lawyer as soon as possible. At Pitta & Baione LLP, we routinely assist clients with the WTCHP claims process, in addition to helping them pursue compensation through the September 11th Victim Compensation Fund (VCF). To find out whether you qualify to receive medical benefits under the WTCHP or compensation under the VCF, reach out to the 9/11 lawyers of Pitta & Baione LLP today by calling (844) 982-2667 or by submitting a case inquiry through our website.